Unusual Machines' stock price action is heating up again and may lead to another solid increase. The Q2 results are the trigger for this meme-quality stock.
Global media and publishing company News Corp (NASDAQ:NWSA) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $2.11 billion. Its non-GAAP profit of $0.89 per share was significantly above analysts’ consensus estimates.
Diversified solutions provider Matthews International (NASDAQ:MATW) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 18.3% year on year to $349.4 million. Its non-GAAP profit of $0.28 per share was 30.2% above analysts’ consensus estimates.
Electrical energy control systems manufacturer Powell (NYSE:POWL) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year on year at $286.3 million. Its GAAP profit of $3.96 per share was 5% above analysts’ consensus estimates.
Zebra Technologies is set up for a stock price rebound that could take it well above the $400 level by early 2026. Analysts are optimistic and raising targets.
Residential swimming pool manufacturer Latham (NASDAQ:SWIM) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 7.8% year on year to $172.6 million. On the other hand, the company’s full-year revenue guidance of $550 million at the midpoint came in 1.1% above analysts’ estimates. Its GAAP profit of $0.13 per share was in line with analysts’ consensus estimates.
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.2% year on year to $869.2 million. The company expects the full year’s revenue to be around $3.33 billion, close to analysts’ estimates. Its non-GAAP profit of $0.83 per share was 17.4% above analysts’ consensus estimates.
Advertising and marketing company Zeta Global (NYSE:ZETA) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 35.4% year on year to $308.4 million. Guidance for next quarter’s revenue was better than expected at $328 million at the midpoint, 1.2% above analysts’ estimates.
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 3.6% year on year to $613.9 million. On the other hand, the company’s full-year revenue guidance of $2.71 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.12 per share was significantly above analysts’ consensus estimates.
Restaurant software platform Toast (NYSE:TOST) announced better-than-expected revenue in Q2 CY2025, with sales up 24.8% year on year to $1.55 billion. Its GAAP profit of $0.13 per share was 22.8% above analysts’ consensus estimates.
Insurance holding company Kemper (NYSE:KMPR) missed Wall Street’s revenue expectations in Q2 CY2025, but sales rose 8.4% year on year to $1.23 billion. Its non-GAAP profit of $1.30 per share was 13.8% below analysts’ consensus estimates.
Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.9% year on year to $370.9 million. The company expects the full year’s revenue to be around $1.52 billion, close to analysts’ estimates. Its non-GAAP profit of $1.33 per share was 8.8% above analysts’ consensus estimates.
Payroll and human resources software provider, Paylocity (NASDAQ:PCTY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 12.2% year on year to $400.7 million. Guidance for next quarter’s revenue was better than expected at $400 million at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $1.56 per share was 12.7% above analysts’ consensus estimates.
Building systems company Limbach (NASDAQ:LMB) missed Wall Street’s revenue expectations in Q2 CY2025, but sales rose 16.4% year on year to $142.2 million. On the other hand, the company’s full-year revenue guidance of $665 million at the midpoint came in 6% above analysts’ estimates. Its non-GAAP profit of $0.93 per share was 20.4% above analysts’ consensus estimates.
Luxury electric car manufacturer Lucid (NASDAQ:LCID) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 29.3% year on year to $259.4 million. Its non-GAAP loss of $0.24 per share was 11.1% below analysts’ consensus estimates.
Home automation and security solutions provider Resideo Technologies (NYSE:REZI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 22.3% year on year to $1.94 billion. The company expects next quarter’s revenue to be around $1.88 billion, close to analysts’ estimates. Its non-GAAP profit of $0.66 per share was 24.5% above analysts’ consensus estimates.
